Combined human il-18 and anticd20 antibody cancer treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 38/20 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2681851

The present invention relates generally to the use of human IL- 18 combinations in the treatment of cancers. In particular, the present invention relates to combination of human IL- 18 and an anti-CD20 antibody.

La présente invention concerne d'une manière générale l'utilisation de l'IL-18 humaine en combinaison dans le traitement de cancers. Cette invention concerne en particulier l'utilisation de l'IL-18 humaine combinée à un anticorps anti-CD20.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined human il-18 and anticd20 antibody cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined human il-18 and anticd20 antibody cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined human il-18 and anticd20 antibody cancer treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1590610

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.